Çelebi N - Search Results

1

In Vitro Cellular Uptake and Insulin Secretion Studies on INS-1E Cells of Exendin-4 Loaded Self Nanoemulsifying Drug Delivery Systems.

Çelik Tekeli M, Yalçin Y, Verdi H, Aktaş Y, Çelebi N. Çelik Tekeli M, et al. Among authors: celebi n. Pharm Dev Technol. 2024 Oct 30:1-17. doi: 10.1080/10837450.2024.2423823. Online ahead of print. Pharm Dev Technol. 2024. PMID: 39474799

2

Development and characterization of exendin-4 loaded self-nanoemulsifying system and in vitro evaluation on Caco-2 cell line.

Aktas Y, Celik Tekeli M, Celebi N. Aktas Y, et al. Among authors: celebi n. J Microencapsul. 2020 Jan;37(1):41-51. doi: 10.1080/02652048.2019.1692945. J Microencapsul. 2020. PMID: 31714163

3

Evaluation of the hypoglycemic effect of exendin-4's new oral self-nanoemulsifying system in rats.

Celik-Tekeli M, Celebi N, Tekeli MY, Aktas Y. Celik-Tekeli M, et al. Among authors: celebi n. Eur J Pharm Sci. 2021 Mar 1;158:105644. doi: 10.1016/j.ejps.2020.105644. Epub 2020 Nov 13. Eur J Pharm Sci. 2021. PMID: 33197556

4

Oral self-nanoemulsifying formulation of GLP-1 agonist peptide exendin-4: development, characterization and permeability assesment on Caco-2 cell monolayer.

Tekeli MC, Aktas Y, Celebi N. Tekeli MC, et al. Among authors: celebi n. Amino Acids. 2021 Jan;53(1):73-88. doi: 10.1007/s00726-020-02926-0. Epub 2021 Jan 4. Amino Acids. 2021. PMID: 33398527

5

Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines.

Gülbağ Pınar S, Pezik E, Mutlu Ağardan B, Çelebi N. Gülbağ Pınar S, et al. Among authors: celebi n. Pharm Dev Technol. 2022 Jan;27(1):52-62. doi: 10.1080/10837450.2021.2020817. Epub 2021 Dec 29. Pharm Dev Technol. 2022. PMID: 34931593

6

New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system.

Gülbağ S, Yılmaz Usta D, Gültekin HE, Oktay AN, Demirtaş Ö, Karaküçük A, Çelebi N. Gülbağ S, et al. Among authors: celebi n. Pharm Dev Technol. 2018 Jun;23(5):512-519. doi: 10.1080/10837450.2017.1345941. Epub 2017 Jul 18. Pharm Dev Technol. 2018. PMID: 28657404

7

The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions.

Oktay AN, Ilbasmis-Tamer S, Celebi N. Oktay AN, et al. Among authors: celebi n. Pharm Dev Technol. 2019 Dec;24(10):1278-1286. doi: 10.1080/10837450.2019.1667384. Pharm Dev Technol. 2019. PMID: 31535942

8

Ritonavir nanosuspensions prepared by microfluidization with enhanced solubility and desirable immunological properties.

Karakucuk A, Canpinar H, Celebi N. Karakucuk A, et al. Among authors: celebi n. Pharm Dev Technol. 2022 Dec;27(10):1027-1037. doi: 10.1080/10837450.2022.2145309. Epub 2022 Nov 14. Pharm Dev Technol. 2022. PMID: 36343117

9

Controlled delivery of peptides and proteins.

Degim IT, Celebi N. Degim IT, et al. Among authors: celebi n. Curr Pharm Des. 2007;13(1):99-117. doi: 10.2174/138161207779313795. Curr Pharm Des. 2007. PMID: 17266590 Review.

10

In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals.

Karaküçük A, Taşhan E, Öztürk N, Çelebi N. Karaküçük A, et al. Among authors: celebi n. Turk J Pharm Sci. 2021 Apr 20;18(2):223-227. doi: 10.4274/tjps.galenos.2020.67366. Turk J Pharm Sci. 2021. PMID: 33902264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters